Literature DB >> 27006357

The National Practice Benchmark for Oncology: 2015 Report for 2014 Data.

Carla Balch1, John D Ogle1, James L Senese2.   

Abstract

The National Practice Benchmark (NPB) is a unique tool used to measure oncology practices against others across the country in a meaningful way despite variations in practice demographics, size, and setting. In today's challenging economic environment, each practice positions service offerings and competitive advantages to attract patients. Although the data in the NPB report are primarily reported by community oncology practices, the business structure and arrangements with regional health care systems are also reflected in the benchmark report. The ability to produce detailed metrics is an accomplishment of excellence in business and clinical management. With these metrics, a practice should be able to measure and analyze its current business practices and make appropriate changes, if necessary. In this report, we build on the foundation initially established by Oncology Metrics (acquired by Flatiron Health in 2014) over years of data collection and refine definitions to deliver the NPB, which is uniquely meaningful in the oncology market.
Copyright © 2016 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2016        PMID: 27006357      PMCID: PMC5015450          DOI: 10.1200/JOP.2015.008458

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  1 in total

1.  The National Practice Benchmark for oncology, 2014 report on 2013 data.

Authors:  Elaine L Towle; Thomas R Barr; James L Senese
Journal:  J Oncol Pract       Date:  2014-11       Impact factor: 3.840

  1 in total
  4 in total

1.  Medical oncology workload in Canada: infrastructure, supports, and delivery of clinical care.

Authors:  A Fundytus; W M Hopman; N Hammad; J J Biagi; R Sullivan; V Vanderpuye; B Seruga; G Lopes; M Sengar; M D Brundage; C M Booth
Journal:  Curr Oncol       Date:  2018-06-28       Impact factor: 3.677

Review 2.  Benchmarks for Academic Oncology Faculty.

Authors:  Lowell Anthony; George Atweh; Ravi Bhatia; Lisa A Carey; Jenny C Chang; Martin J Edelman; Philip W Kantoff; Merry Jennifer Markham; Wells Messersmith; Edward L Nelson; Kurt Oettel; Ruth O'Regan; Claire F Verschraegen; Julie M Vose
Journal:  JCO Oncol Pract       Date:  2020-09-30

3.  Best Practice Approach to Successful Conversion of Fosaprepitant to Aprepitant IV in a Large Multisite Community Oncology Infusion Center: A Retrospective Analysis.

Authors:  Derek Burns; Julianna Kula; Scott Marshall; Elizabeth Ashworth; Matthew Ornelas
Journal:  Adv Ther       Date:  2020-05-23       Impact factor: 3.845

4.  Cancer care workforce in Africa: perspectives from a global survey.

Authors:  Verna Vanderpuye; Nazik Hammad; Yehoda Martei; Wilma M Hopman; Adam Fundytus; Richard Sullivan; Bostjan Seruga; Gilberto Lopes; Manju Sengar; Michael D Brundage; Christopher M Booth
Journal:  Infect Agent Cancer       Date:  2019-05-21       Impact factor: 2.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.